Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enobosarm add-on study in ER+/AR+ breast cancer
NCT02746328Phase 2Withdrawn
- Sponsor
- GTx
- Start
- Apr 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enobosarm in breast cancer, sponsored by GTx. Planned start Apr 2016; status: withdrawn.
02
Drugs
enobosarm
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02746328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746328.